[1]
“Clinical and prognostic value of the initial doubling time of prostate-specific antigen in prostate cancer patients”, Вопр. онкол., vol. 58, no. 6, pp. 817–820, Dec. 2012, doi: 10.37469/0507-3758-2012-58-6-817-820.